about
Whole-exome sequencing supports genetic heterogeneity in childhood apraxia of speech.Achieving high-sensitivity for clinical applications using augmented exome sequencingBioinformatics for cancer immunology and immunotherapySustained proliferation in cancer: Mechanisms and novel therapeutic targetsDetection of circulating tumor DNA in early- and late-stage human malignanciesTranslating leukemia stem cells into the clinical setting: Harmonizing the heterogeneity.Precision oncology for acute myeloid leukemia using a knowledge bank approach.Tumor haplotype assembly algorithms for cancer genomics.A novel network regularized matrix decomposition method to detect mutated cancer genes in tumour samples with inter-patient heterogeneity.Patient-derived xenografts, the cancer stem cell paradigm, and cancer pathobiology in the 21st century.Chapter 6: Structural variation and medical genomics.A survey of tools for variant analysis of next-generation genome sequencing data.Characterization of structural variants with single molecule and hybrid sequencing approaches.Integrated platform for genome-wide screening and construction of high-density genetic interaction maps in mammalian cells.Onco-STS: a web-based laboratory information management system for sample and analysis tracking in oncogenomic experiments.Somatic mutations, viral integration and epigenetic modification in the evolution of hepatitis B virus-induced hepatocellular carcinomaNew concepts in breast cancer genomics and geneticsGenome Modeling System: A Knowledge Management Platform for Genomics.Capture-based next-generation sequencing reveals multiple actionable mutations in cancer patients failed in traditional testing.Genome evolution during progression to breast cancer.DNA sequencing methods in human genetics and disease research.Clinical applications of next-generation sequencing in colorectal cancersPersonalized immune-interception of cancer and the battle of two adaptive systems--when is the time right?Next-generation sequencing: application in liver cancer-past, present and future?Intratumoral heterogeneity, its contribution to therapy resistance and methodological caveats to assessment.NetNorM: Capturing cancer-relevant information in somatic exome mutation data with gene networks for cancer stratification and prognosis.Establishment of a novel human medulloblastoma cell line characterized by highly aggressive stem-like cells.A mutation profile for top-k patient search exploiting Gene-Ontology and orthogonal non-negative matrix factorization.Distribution of circulating tumor DNA in lung cancer: analysis of the primary lung and bone marrow along with the pulmonary venous and peripheral blood.Tracking the clonal origin of lethal prostate cancer.Network-based stratification of tumor mutations.Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing.Informatics for cancer immunotherapy.Detecting cancer in primary care: Where does early diagnosis stop and overdiagnosis begin?
P2860
Q21198726-AB85592D-CEAC-426D-B171-F3B6D9D8D444Q22000581-D628CFF6-27B7-457A-A541-C8986DD47FA6Q26864876-6606CF96-6F59-4D77-8D81-E3ED53FA81DAQ28396388-4E3DAE24-7F31-443B-BD86-F6A7AF7DF864Q29615778-552ABE42-5355-485A-8DBE-44582CC873E8Q30244186-6280C89C-902B-4279-BCCE-3DFD15D9FD1AQ33458896-A2D65A26-50BF-4623-9686-0C0DC52ABDC7Q33732433-CE956BB7-4118-4D72-B0A6-446EC5CE57AFQ33767347-8BDB1A48-2C42-40D0-A25F-D983AA2FDF79Q34037747-EDB64DFC-A2B7-42BA-928C-41B943344F4BQ34539666-54A3F16E-939D-4179-B4EA-D7CE255072E9Q34557864-29078411-25B5-4CB4-9A81-BC745E2EC71FQ34621399-9C4C9009-58C1-4DF3-8FB3-C9F05BEFBA58Q34759985-4BF1D235-B75E-4152-9EA9-DDA542642C62Q34887923-F588F988-80F4-4923-910B-359AC82BF579Q35029955-ECEC0893-6E26-4F79-9564-5EE42C360EE3Q35258057-A59BA7F3-F2D4-490E-8640-C80C9412F7A0Q35836071-2BA82DE6-4358-47CD-8E65-843E410F0510Q36902969-7CE6CFD0-6ECB-4BA0-A8A1-65A1A8D83F71Q36973612-AC6E4296-BA9E-4711-8D94-1C759407F2DCQ37159006-05BFB262-A63F-40A6-BF79-F72A63D7ECC8Q37266384-44893584-342E-4510-872E-17F9A198183BQ38076107-2EA6B599-DE9B-4044-BAEF-FFCEEE792AFAQ38113220-3E38F268-419C-4E64-B8F9-98F631FA1F4BQ38222758-03D3F24C-CD02-42E7-8519-FD660A434EEBQ38708733-2CCAF9FD-FA6E-444C-A99F-E3C9A5F3B0DCQ38836198-893D2FC9-B367-436B-99EC-A4785A403DE1Q40698095-CD19B0EA-79FF-44D5-8C03-840FE20E2CD8Q41708857-623A9AC5-ACEF-45EA-8856-9911E8371CFFQ41762568-B9AA7D25-2E59-4AF6-8692-916AA72BB40CQ42034112-E5C2381C-18BE-4254-8688-005912A6ADBAQ47163678-1C4F7092-80E6-423B-B8C8-A07814C4C2F0Q47290509-9E7CCE33-ED69-4ECD-9B1C-49B27F3A46CCQ48253978-B5D0E541-11F4-40E4-9B51-853775B1D594
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Genome sequencing and cancer
@ast
Genome sequencing and cancer
@en
Genome sequencing and cancer
@nl
type
label
Genome sequencing and cancer
@ast
Genome sequencing and cancer
@en
Genome sequencing and cancer
@nl
prefLabel
Genome sequencing and cancer
@ast
Genome sequencing and cancer
@en
Genome sequencing and cancer
@nl
P2860
P1476
Genome sequencing and cancer
@en
P2860
P304
P356
10.1016/J.GDE.2012.03.005
P407
P577
2012-06-01T00:00:00Z